EP Patent

EP4297868A4 — USE OF APREPITANT FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Assigned to Hoth Therapeutics Inc · Expires 2025-01-08 · 1y expired

What this patent protects

Patent listed against Emend.

Drugs covered by this patent

Emend (APREPITANT) · Merck & Co.

Patent Metadata

Patent number: EP4297868A4
Jurisdiction: EP
Classification: —
Expires: 2025-01-08
Drug substance claim: No
Drug product claim: No
Assignee: Hoth Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.